In this Issue
The Unknown Unknowns
Associate Medical Editor’s Page
By Arsham Sheybani, MD
Studying neuroregeneration and neuroprotection.
By Melissa L. Cooper, BS, and David J. Calkins, PhD
Side effects, health risks, and a short duration of action limit the usefulness of this drug.
By Thomas A. Graul, MD
COMPLEX CASE MANAGEMENT
Surgeons discuss a diagnosis and the related treatment options.
By William H. Bray, MD; Jacob W. Brubaker, MD; Leon W. Herndon, MD; Inder Paul Singh, MD; and Steven R. Sarkisian Jr, MD
A new tool for managing power surprises with toric IOLs.
By Richard Tipperman, MD
Insights from an investigator of the technology.
An Interview with Vance Thompson, MD, FACS
The ability of a single optical coherence tomography instrument to image the whole eye could provide new insights and make testing quicker.
By Gillian McDermott, Editor-in-Chief, Clinical Content, Anterior Segment, BMC Vision
Slow-coagulation TSCPC: the ultimate minimally invasive glaucoma surgery?
By Mohamed S. Sayed, MD, and Richard K. Lee, MD, PhD
RESIDENTS & FELLOWS
New challenges unfold with glaucoma surgery.
By Eunice Yook, MD
COVER STORY | MIGS: THE UNKNOWN UNKNOWNS
With more options come more questions.
By John T. Lind, MD, MS
Identifying the wrong candidates can be as important as choosing the right ones.
By Manjool Shah, MD
A close examination raises several questions for patients in whom a very low target IOP is needed.
By Eileen Choudhury Bowden, MD, and Joseph F. Panarelli, MD
Tips and tricks for improved surgical results.
By Chelvin Sng, MBBChir, MA, FRCS(Ed), and Jing Wang, MD, FRCSC
Marketing is a powerful tool to connect with patients.